Shazia Ali

3.8k total citations · 2 hit papers
37 papers, 1.0k citations indexed

About

Shazia Ali is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Shazia Ali has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 14 papers in Cardiology and Cardiovascular Medicine and 11 papers in Cancer Research. Recurrent topics in Shazia Ali's work include Lipoproteins and Cardiovascular Health (20 papers), Lipid metabolism and disorders (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Shazia Ali is often cited by papers focused on Lipoproteins and Cardiovascular Health (20 papers), Lipid metabolism and disorders (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Shazia Ali collaborates with scholars based in United States, Canada and South Africa. Shazia Ali's co-authors include Robert Pordy, Robert S. Rosenson, Daniel Gaudet, Nagwa Khilla, Poulabi Banerjee, Paolo Rubba, John J.P. Kastelein, Daniel A. Gipe, Kuo‐Chen Chan and Frederick J. Raal and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Shazia Ali

33 papers receiving 997 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evinacumab for Homozygous Familial Hypercholesterolemia

2020 470 citations Frederick J. Raal, Robert S. Rosenson et al. New England Journal of Medicine profile →
Evinacumab in Patients with Refractory Hypercholesterolemia

2020 215 citations Robert S. Rosenson, Lesley Burgess et al. New England Journal of Medicine profile →

Peers

Shazia Ali

SURGE

CCM

EDM

Nagwa Khilla United States

Laurens F. Reeskamp Netherlands

Ovidio Muñiz-Grijalvo Spain

Kuo‐Chen Chan United States

Ilse K. Luirink Netherlands

Dick C.G. Basart Netherlands

Paul Ziajka United States

Pia R. Kamstrup Denmark

Barbara Sjouke Netherlands

Tsuyoshi Nozue Japan

Nagwa Khilla United States

Shazia Ali

610 ×0.9

SURGE

474 ×0.9

CCM

314 ×0.9

EDM

248 ×0.9

110 ×0.9

Citations per year, relative to Shazia Ali Shazia Ali (= 1×) peers Nagwa Khilla

Countries citing papers authored by Shazia Ali

Since Specialization

Citations

This map shows the geographic impact of Shazia Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shazia Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shazia Ali more than expected).

Fields of papers citing papers by Shazia Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shazia Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shazia Ali. The network helps show where Shazia Ali may publish in the future.

Co-authorship network of co-authors of Shazia Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Shazia Ali. A scholar is included among the top collaborators of Shazia Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shazia Ali. Shazia Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Shazia, et al.. (2024). Implementing ML and IoT-Based Predictive Traffic-Management Systems for Smart Cities. 1–7.

Rosenson, Robert S., Daniel J. Rader, Shazia Ali, et al.. (2024). Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials. Cardiovascular Drugs and Therapy. 39(4). 925–931. 8 indexed citations

Wiegman, Albert, Susanne Greber‐Platzer, Shazia Ali, et al.. (2023). Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia. Circulation. 149(5). 343–353. 41 indexed citations

Raal, Frederick J., Robert S. Rosenson, Laurens F. Reeskamp, et al.. (2023). The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia. JACC Advances. 2(9). 100648–100648. 15 indexed citations

Rosenson, Robert S., Lesley Burgess, Christoph Ebenbichler, et al.. (2023). Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia. JAMA Cardiology. 8(11). 1070–1070. 21 indexed citations

AlMahadin, Ghayth, et al.. (2023). Enabling Smart Banking AI and IoT: Challenges and Opportunities. 1–6. 1 indexed citations

Somersan-Karakaya, Selin, Eleftherios Mylonakis, Ernesto Oviedo‐Orta, et al.. (2023). Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial. Open Forum Infectious Diseases. 10(5). ofad211–ofad211. 1 indexed citations

Sadiq, Noman, et al.. (2023). Modulation of Heart Rate Variability in Stressed Medical Students Via Breathing Exercise. 17(1). 117–119. 1 indexed citations

Hooper, Andrea T., Diana Rofail, Kusha Mohammadi, et al.. (2023). Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles. Scientific Reports. 13(1). 12784–12784. 3 indexed citations

10.

Ali, Shazia, et al.. (2023). Multimodal Temporal Pattern Discrimination Is Encoded in Visual Cortical Dynamics. eNeuro. 10(7). ENEURO.0047–23.2023.

11.

Hooper, Andrea T., Selin Somersan-Karakaya, Shane McCarthy, et al.. (2022). Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies. mBio. 13(6). e0169922–e0169922. 7 indexed citations

12.

Reeskamp, Laurens F., Susanne Greber‐Platzer, Samir Saheb, et al.. (2021). EVINACUMAB MARKEDLY REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN ADOLESCENT PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA. Journal of the American College of Cardiology. 77(18). 121–121. 1 indexed citations

13.

Rasool, Muhammad Fawad, Shazia Ali, Sundus Khalid, et al.. (2021). Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases. Scientific Reports. 11(1). 8589–8589. 29 indexed citations

14.

Ali, Shazia, et al.. (2020). RIPHAH MEDICAL, DENTAL & PHYSIOTHERAPY FACULTY EXPERIENCE WITH ONLINE EDUCATION – COVID-19 PANDEMIC. SHILAP Revista de lepidopterología. 2 indexed citations

15.

Raal, Frederick J., Robert S. Rosenson, Laurens F. Reeskamp, et al.. (2020). Evinacumab for Homozygous Familial Hypercholesterolemia. New England Journal of Medicine. 383(8). 711–720. 470 indexed citations breakdown →

16.

Harada‐Shiba, Mariko, Shazia Ali, Daniel A. Gipe, et al.. (2020). A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects. Atherosclerosis. 314. 33–40. 35 indexed citations

17.

Blom, Dirk, Mariko Harada‐Shiba, Paolo Rubba, et al.. (2020). Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia. Journal of the American College of Cardiology. 76(2). 131–142. 119 indexed citations

18.

Rosenson, Robert S., Frederick J. Raal, Laurens F. Reeskamp, et al.. (2020). The Efficacy and Safety of Evinacumab in Homozygous Familial Hypercholesterolemia Patients with Little to No Low-Density Lipoprotein Receptor Activity. Journal of clinical lipidology. 14(4). 552–552. 1 indexed citations

19.

Raal, Frederick J., Robert S. Rosenson, Laurens F. Reeskamp, et al.. (2020). Abstract 14267: Evinacumab Lowers LDL-C in Patients With Homozygous Familial Hypercholesterolemia Irrespective of Background Lipid-lowering Medication. Circulation. 142(Suppl_3). 2 indexed citations

20.

Jabeen, Kauser, Joveria Farooqi, Sadia Hanif, et al.. (2016). Effect of time duration of digestion/decontamination technique on yield of mycobacteria and contamination rates from sterile body fluids (pleural and ascitic fluid) and pus specimens. International Journal of Mycobacteriology. 5. S195–S196. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact